Reading...
Play button
Play button
Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
11 Cards in this Set
- Front
- Back
|
Acarbose
Miglitol Voglibose |
Alpha-Glucosidase Inhibitors
|
|
|
Lispro (ligtning fast)
Regular (short-acting) Semilente (short-acting) NPH (intermediate-acting) Ultralente (long-acting) Glargine (long-acting) |
Exogenous Insulin
|
|
|
Acetohexamide
Chlorpropamide Tolazamide Tolbutamide Glimepiride Glipizide Glibenclamide Gliclazide Gliquidone |
Sulfonylureas
inhibit the beta cell potassium/ATP channel at SUR1 subunit increasing insulin release |
|
|
Nateglinide
Repaglinide |
Meglitinides
inhibit the beta cell potassium/ATP channel at SUR1 subunit increasing insulin release |
|
|
Pioglitazone
Rosiglitazone |
Thiazolidinediones (TZD's)
bind PPAR-gamma to increase cell sensitivity to insulin |
|
|
Metformin
|
Biguanide
inhibits anabolism of glucose and increases cell sensitivity to insulin |
|
|
Exenatide
|
GLP-1 (Glucagon-like peptide-1) receptor agonist
increases insulin, inhibits glucagon, delays gastric emptying |
|
|
Sitagliptin
|
DPP-IV (dipeptidyl peptidase-IV) inhibitor
slows inactivation of GLP-1 and other incretin hormones |
|
|
Diazoxide
|
binds to beta cell potassium/ATP channel keeping it hyperpolarized to inhibit insulin release
|
|
|
Octreotide
|
Somatostatin Analogue
Inhibits GHRH release as well as hormone-secreting tumors (eg. insulinomas, glucagonomas, adenomas) |
|
|
Exogenous Glucagon
|
Stimulates gluconeogenesis and glycogenolysis
|
